Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells.

Major histocompatibility complex class II (MHC II) molecules are expressed on the surface of antigen-presenting cells and display short bound peptide fragments derived from self- and nonself antigens. These peptide-MHC complexes function to maintain immunological tolerance in the case of self-antigens and initiate the CD4(+) T cell response in the case of foreign proteins. Here we report the application of LC-MS/MS analysis to identify MHC II peptides derived from endogenous proteins expressed in freshly isolated murine splenic DCs. The cell number was enriched in vivo upon treatment with Flt3L-B16 melanoma cells. In a typical experiment, starting with about 5 × 10(8) splenic DCs, we were able to reliably identify a repertoire of over 100 MHC II peptides originating from about 55 proteins localized in membrane (23%), intracellular (26%), endolysosomal (12%), nuclear (14%), and extracellular (25%) compartments. Using synthetic isotopically labeled peptides corresponding to the sequences of representative bound MHC II peptides, we quantified by LC-MS relative peptide abundance. In a single experiment, peptides were detected in a wide concentration range spanning from 2.5 fmol/μL to 12 pmol/μL or from approximately 13 to 2 × 10(5) copies per DC. These peptides were found in similar amounts on B cells where we detected about 80 peptides originating from 55 proteins distributed homogenously within the same cellular compartments as in DCs. About 90 different binding motifs predicted by the epitope prediction algorithm were found within the sequences of the identified MHC II peptides. These results set a foundation for future studies to quantitatively investigate the MHC II repertoire on DCs generated under different immunization conditions.

[1]  A. Lanzavecchia,et al.  Activation of the Flt3 signal transduction cascade rescues and enhances type I interferon–producing and dendritic cell development , 2006, The Journal of experimental medicine.

[2]  H. de la Salle,et al.  Gene induction during differentiation of human monocytes into dendritic cells: an integrated study at the RNA and protein levels , 2001, Functional & Integrative Genomics.

[3]  E. Unanue,et al.  Quantitation of Lysozyme Peptides Bound to Class II MHC Molecules Indicates Very Large Differences in Levels of Presentation1 , 2001, The Journal of Immunology.

[4]  Gaurav Kumar,et al.  Network analysis of human protein location , 2010, BMC Bioinformatics.

[5]  Nina Hillen,et al.  Contribution of mass spectrometry-based proteomics to immunology , 2006, Expert review of proteomics.

[6]  C. Reis e Sousa Dendritic cells in a mature age , 2006, Nature reviews. Immunology.

[7]  V. Engelhard,et al.  Structure of peptides associated with class I and class II MHC molecules. , 1994, Annual review of immunology.

[8]  A. Rudensky,et al.  In vivo MHC class II presentation of cytosolic proteins revealed by rapid automated tandem mass spectrometry and functional analyses , 2001, European journal of immunology.

[9]  R. Steinman,et al.  Differential Antigen Processing by Dendritic Cell Subsets in Vivo , 2007, Science.

[10]  William S. Lane,et al.  Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size , 1992, Nature.

[11]  Peng Yang,et al.  Components of the antigen processing and presentation pathway revealed by gene expression microarray analysis following B cell antigen receptor (BCR) stimulation , 2006, BMC Bioinformatics.

[12]  I. Weissman,et al.  Flt3 Ligand Regulates Dendritic Cell Development from Flt3+ Lymphoid and Myeloid-committed Progenitors to Flt3+ Dendritic Cells In Vivo , 2003, The Journal of experimental medicine.

[13]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[14]  B. Pulendran,et al.  Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. , 1997, Journal of immunology.

[15]  Michael Meyer-Hermann,et al.  Germinal Center Dynamics Revealed by Multiphoton Microscopy with a Photoactivatable Fluorescent Reporter , 2010, Cell.

[16]  Xiaohui S. Xie,et al.  A Mammalian Organelle Map by Protein Correlation Profiling , 2006, Cell.

[17]  O. Bakke,et al.  Ubiquitination regulates MHC class II-peptide complex retention and degradation in dendritic cells , 2010, Proceedings of the National Academy of Sciences.

[18]  R. Steinman,et al.  Dendritic cells: translating innate to adaptive immunity. , 2006, Current topics in microbiology and immunology.

[19]  C. Reis e Sousa,et al.  Microbial and T Cell-Derived Stimuli Regulate Antigen Presentation by Dendritic Cells In Vivo1 , 2000, The Journal of Immunology.

[20]  S. R. Pereira,et al.  Changes in the proteomic profile during differentiation and maturation of human monocyte‐derived dendritic cells stimulated with granulocyte macrophage colony stimulating factor/interleukin‐4 and lipopolysaccharide , 2005, Proteomics.

[21]  B. Kuster,et al.  Proteomics: a pragmatic perspective , 2010, Nature Biotechnology.

[22]  Forest M White,et al.  Analysis of MHC Class II Antigen Processing by Quantitation of Peptides that Constitute Nested Sets , 2002, The Journal of Immunology.

[23]  S. Tura,et al.  Stem Cell Factor and FLT3-Ligand Are Strictly Required to Sustain the Long-Term Expansion of Primitive CD34+DR− Dendritic Cell Precursors , 2001, The Journal of Immunology.

[24]  David E. Misek,et al.  Profiling Changes in Gene Expression during Differentiation and Maturation of Monocyte-derived Dendritic Cells Using Both Oligonucleotide Microarrays and Proteomics* , 2001, The Journal of Biological Chemistry.

[25]  E. Jaffee,et al.  Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Strominger,et al.  Perfusion chromatography for very rapid purification of class I and II MHC proteins. , 2000, Journal of immunological methods.

[27]  H. Rammensee,et al.  SYFPEITHI: database for MHC ligands and peptide motifs , 1999, Immunogenetics.

[28]  S. Amigorena,et al.  Phagocytosis and antigen presentation in dendritic cells , 2007, Immunological reviews.

[29]  H. Rammensee,et al.  Autophagy promotes MHC class II presentation of peptides from intracellular source proteins , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Steinman,et al.  SIGN-R1, a novel C-type lectin expressed by marginal zone macrophages in spleen, mediates uptake of the polysaccharide dextran. , 2003, International immunology.

[31]  L. Karlsson,et al.  Nonclassical MHC class II molecules. , 2000, Annual review of immunology.

[32]  Antonio Lanzavecchia,et al.  Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells , 1997, Nature.

[33]  Emil R Unanue,et al.  The wide diversity and complexity of peptides bound to class II MHC molecules. , 2006, Current opinion in immunology.

[34]  G. Kelsoe Life and death in germinal centers (redux). , 1996, Immunity.

[35]  Zheng Pu,et al.  Amino-Terminal Flanking Residues Determine the Conformation of a Peptide–Class II MHC Complex1 , 2006, The Journal of Immunology.

[36]  F. Pontén,et al.  Large-scale protein profiling in human cell lines using antibody-based proteomics. , 2011, Journal of proteome research.

[37]  Kenneth G. C. Smith,et al.  The B-cell response to protein antigens in immunity and transplantation. , 2008, Transplantation.

[38]  Ruslan Medzhitov,et al.  Pattern recognition receptors and control of adaptive immunity , 2009, Immunological reviews.

[39]  Meredith O'Keeffe,et al.  Effects of administration of progenipoietin 1, Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice. , 2002, Blood.

[40]  Ira Mellman,et al.  Cell biology of antigen processing in vitro and in vivo. , 2005, Annual review of immunology.

[41]  Shalin H. Naik,et al.  Steady-state and inflammatory dendritic-cell development , 2007, Nature Reviews Immunology.

[42]  R. Steinman,et al.  Efficient Presentation of Phagocytosed Cellular Fragments on the Major Histocompatibility Complex Class II Products of Dendritic Cells , 1998, The Journal of experimental medicine.

[43]  Michel C Nussenzweig,et al.  Tolerogenic dendritic cells. , 2003, Annual review of immunology.

[44]  P. Guermonprez,et al.  Antigen presentation by B lymphocytes: how receptor signaling directs membrane trafficking. , 2007, Current opinion in immunology.

[45]  I. Mellman,et al.  Mature dendritic cells use endocytic receptors to capture and present antigens , 2010, Proceedings of the National Academy of Sciences.

[46]  R. Steinman,et al.  Developmental regulation of MHC class II transport in mouse dendritic cells , 1997, Nature.

[47]  E. Maraskovsky,et al.  Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified , 1996, The Journal of experimental medicine.

[48]  A. D'amico,et al.  The Early Progenitors of Mouse Dendritic Cells and Plasmacytoid Predendritic Cells Are within the Bone Marrow Hemopoietic Precursors Expressing Flt3 , 2003, The Journal of experimental medicine.

[49]  D. Wellings,et al.  Standard Fmoc protocols. , 1997, Methods in enzymology.

[50]  R. Steinman,et al.  Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant , 2009, The Journal of experimental medicine.

[51]  Ira Mellman,et al.  The Formation of Immunogenic Major Histocompatibility Complex Class II–Peptide Ligands in Lysosomal Compartments of Dendritic Cells Is Regulated by Inflammatory Stimuli , 2000, The Journal of experimental medicine.

[52]  R. Steinman,et al.  HIV gag protein is efficiently cross‐presented when targeted with an antibody towards the DEC‐205 receptor in Flt3 ligand‐mobilized murine DC , 2009, European journal of immunology.

[53]  R. Medzhitov,et al.  Toll-dependent selection of microbial antigens for presentation by dendritic cells , 2006, Nature.

[54]  S. Gygi,et al.  Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[55]  A. Trzeciak,et al.  New coupling reagents in peptide chemistry , 1989 .

[56]  Ira Mellman,et al.  Dendritic Cells Specialized and Regulated Antigen Processing Machines , 2001, Cell.

[57]  H. Rammensee,et al.  Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis. , 2007, The Journal of clinical investigation.

[58]  Robert Weissert,et al.  Naturally Presented Peptides on Major Histocompatibility Complex I and II Molecules Eluted from Central Nervous System of Multiple Sclerosis Patients* , 2009, Molecular & Cellular Proteomics.

[59]  M. Nussenzweig,et al.  Antigen receptor diversification and chromosome translocations , 2007, Nature Immunology.

[60]  A. Rudensky,et al.  Sequence analysis of peptides bound to MHC class II molecules , 1991, Nature.

[61]  Sébastien Lemieux,et al.  Deletion of Immunoproteasome Subunits Imprints on the Transcriptome and Has a Broad Impact on Peptides Presented by Major Histocompatibility Complex I molecules* , 2010, Molecular & Cellular Proteomics.

[62]  Bindu Nanduri,et al.  HPIDB - a unified resource for host-pathogen interactions , 2010, BMC Bioinformatics.

[63]  J. Strominger,et al.  The ins and outs of MHC class II proteins in dendritic cells. , 2006, Immunity.

[64]  A. Rudensky,et al.  In Vivo Analysis of Dendritic Cell Development and Homeostasis , 2009, Science.

[65]  M. Nussenzweig,et al.  Breaking down cell cycle checkpoints and DNA repair during antigen receptor gene assembly , 2007, Oncogene.

[66]  N. Solé,et al.  Optimization of solid-phase synthesis of [Ala8]-dynorphin A , 1992 .

[67]  M. Mann,et al.  Quantitative proteomics reveals subset-specific viral recognition in dendritic cells. , 2010, Immunity.

[68]  F. Ginhoux,et al.  FMS-like tyrosine kinase 3 is required for dendritic cell development in peripheral lymphoid tissues , 2008, Nature Immunology.

[69]  C Danieli,et al.  Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products , 1995, The Journal of experimental medicine.